Phase II Trial Of Medium-Dose VP-16, Cyclophosphamide and Total-Body Irradiation Conditioning Regimen Before Allogeneic Stem Cell Transplantation For Acute Lymphoblastic Leukemia In Adults

被引：0
|
作者：
Goto, Tatsunori
Shigematsu, Akio
Onizuka, Makoto
Fujisawa, Shin
Suzuki, Ritsuro
Atsuta, Yoshiko
Hatanaka, Kazuo
Masuko, Masayoshi
Ito, Toshiro
Kobayashi, Naoki
Kato, Jun
Miyamura, Koichi
Fukuda, Takahiro
Morishima, Yasuo
Imamura, Masahiro
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.544.544
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
544
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia
    Shigematsu, Akio
    Kondo, Takeshi
    Yamamoto, Satoshi
    Sugita, Junichi
    Onozawa, Masahiro
    Kahata, Kaoru
    Endo, Tomoyuki
    Shiratori, Soichi
    Ota, Shuichi
    Ohara, Masato
    Wakasa, Kentaro
    Takahata, Mutsumi
    Takeda, Yukari
    Tanaka, Junji
    Hashino, Satoshi
    Nishio, Mitsufumi
    Koike, Takao
    Asaka, Masahiro
    Imamura, Masahiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (05) : 568 - 575
  • [2] Medium-Dose VP-16 Intensified Conditioning Regimen Is Effective in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
    Sun, Feifei
    Fang, Xiaosheng
    Jiang Yujie
    Sui, Xiaohui
    Liu, Xin
    Wang, Xianghua
    Li, Ying
    Wang, Na
    Zhen, Changqing
    Qu, Huiting
    Fan, Juan
    Xu, Hongzhi
    Wang, Xin
    BLOOD, 2018, 132
  • [3] A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
    Shigematsu, Akio
    Ozawa, Yukiyasu
    Onizuka, Makoto
    Fujisawa, Shin
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Hatanaka, Kazuo
    Masuko, Masayoshi
    Ito, Toshiro
    Kobayashi, Naoki
    Kato, Jun
    Miyamura, Koichi
    Fukuda, Takahiro
    Morishima, Yasuo
    Imamura, Masahiro
    TRANSPLANTATION DIRECT, 2015, 1 (02): : E8
  • [4] Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
    Shigematsu, Akio
    Tanaka, Junji
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Kawase, Takakazu
    Ito, Yoichi M.
    Yamashita, Takuya
    Fukuda, Takahiro
    Kumano, Keiki
    Iwato, Koji
    Yoshiba, Fumiaki
    Kanamori, Heiwa
    Kobayashi, Naoki
    Fukuhara, Takashi
    Morishima, Yasuo
    Imamura, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (05) : 463 - 471
  • [5] Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
    Akio Shigematsu
    Junji Tanaka
    Ritsuro Suzuki
    Yoshiko Atsuta
    Takakazu Kawase
    Yoichi M. Ito
    Takuya Yamashita
    Takahiro Fukuda
    Keiki Kumano
    Koji Iwato
    Fumiaki Yoshiba
    Heiwa Kanamori
    Naoki Kobayashi
    Takashi Fukuhara
    Yasuo Morishima
    Masahiro Imamura
    International Journal of Hematology, 2011, 94 : 463 - 471
  • [6] Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia
    Shigematsu, Akio
    Tanaka, Junji
    Suzuki, Ritsuro
    Kawase, Takakazu
    Akiyama, Hideki
    Fukuda, Takahiro
    Kumano, Keiki
    Yoshiba, Fumiaki
    Kanamori, Heiwa
    Kobayashi, Naoki
    Fukuhara, Takashi
    Imamura, Masahiro
    BLOOD, 2009, 114 (22) : 910 - 911
  • [7] Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
    Yuki Tazawa
    Akio Shigematsu
    Kumiko Kasashi
    Junichi Sugita
    Tomoyuki Endo
    Takeshi Kondo
    Takanori Teshima
    Ken Iseki
    Mitsuru Sugawara
    Yoh Takekuma
    Journal of Pharmaceutical Health Care and Sciences, 2 (1)
  • [8] Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
    Tazawa, Yuki
    Shigematsu, Akio
    Kasashi, Kumiko
    Sugita, Junichi
    Endo, Tomoyuki
    Kondo, Takeshi
    Teshima, Takanori
    Iseki, Ken
    Sugawara, Mitsuru
    Takekuma, Yoh
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2016, 2
  • [9] Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome- positive acute lymphoblastic leukemia in adults
    Harada, Kaito
    Morita-Fujita, Mari
    Fukuda, Takahiro
    Ozawa, Yukiyasu
    Doki, Noriko
    Toyosaki, Masako
    Maruyama, Yumiko
    Kanda, Yoshinobu
    Ashida, Takashi
    Eto, Tetsuya
    Takada, Satoru
    Uchida, Naoyuki
    Ichinohe, Tatsuo
    Kanda, Junya
    Onizuka, Makoto
    Atsuta, Yoshiko
    Kako, Shinichi
    Arai, Yasuyuki
    CYTOTHERAPY, 2022, 24 (09) : 954 - 961
  • [10] Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia
    Mori, Takehiko
    Aisa, Yoshinobu
    Kato, Jun
    Yamane, Akiko
    Nakazato, Tomonori
    Shigematsu, Naoyuki
    Okamoto, Shinichiro
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) : 349 - 353
12345